Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-209
Closed -$7K 2075
2021
Q4
$7K Sell
209
-1,665
-89% -$60.5K ﹤0.01% 1698
2021
Q3
$81K Buy
+1,874
New +$115K ﹤0.01% 1401
2020
Q4
Sell
-1
Closed 1873
2020
Q3
$0 Buy
+1
New +$31 ﹤0.01% 1343
2020
Q1
Sell
-1,421
Closed -$97K 1136
2019
Q4
$97K Buy
1,421
+182
+15% +$11.4K 0.02% 523
2019
Q3
$59K Buy
+1,239
New +$64.6K 0.02% 550
2018
Q4
Sell
-7
Closed -$2K 1037
2018
Q3
$2K Buy
+7
New +$1.62K ﹤0.01% 775
2017
Q3
Sell
-6
Closed -$1K 913
2017
Q2
$1K Sell
6
-19
-76% -$1.62K ﹤0.01% 713
2017
Q1
$2K Sell
25
-89
-78% -$6.17K ﹤0.01% 634
2016
Q4
$8K Sell
114
-386
-77% -$23.8K 0.01% 679
2016
Q3
$30K Buy
+500
New +$27.9K 0.02% 534

Other funds holding INGN

Point72 Hong Kong's INGN Position: Q1 2022 in Review

Point72 Hong Kong sold out of Inogen (INGN) in Q1 2022, closing a stake of 209 shares — an estimated $7K sold.

Point72 Hong Kong first reported a position in INGN in Q3 2016 and held it in 10 quarters. The position peaked at $97K in Q4 2019. 149 funds tracked by Wall St. Rank hold INGN as of Q1 2022.

  • Point72 Hong Kong reported no remaining Inogen position as of Q1 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 209 Inogen shares in Q1 2022, an estimated $7K.
  • Point72 Hong Kong first reported a position in Inogen in Q3 2016 and held it in 10 quarters.
  • Point72 Hong Kong's Inogen position peaked at $97K in Q4 2019.
  • 149 funds tracked by Wall St. Rank held Inogen as of Q1 2022.

Based on Point72 Hong Kong's 13F filing for Q1 2022, filed 16 May 2022.